These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 32331706)
1. C-Reactive Protein Concentration in Steady-State Bronchiectasis: Prognostic Value of Future Severe Exacerbations. Data From the Spanish Registry of Bronchiectasis (RIBRON). Posadas T; Oscullo G; Zaldivar E; Villa C; Dobarganes Y; Girón R; Olveira C; Maíz L; García-Clemente M; Sibila O; Golpe R; Rodríguez J; Barreiro E; Rodriguez JL; Menéndez R; Prados C; de la Rosa D; Martinez-García MA; ; Arch Bronconeumol (Engl Ed); 2021 Jan; 57(1):21-27. PubMed ID: 32331706 [TBL] [Abstract][Full Text] [Related]
2. [Respiratory pathogen spectrum in pulmonary exacerbation of bronchiectasis in adults and its association with disease severity]. Gao YH; Guan WJ; Zhu YN; Chen RC; Zhang GJ Zhonghua Jie He He Hu Xi Za Zhi; 2019 Apr; 42(4):254-261. PubMed ID: 30955282 [No Abstract] [Full Text] [Related]
3. RIBRON: The spanish Online Bronchiectasis Registry. Characterization of the First 1912 Patients. Martinez-García MA; Villa C; Dobarganes Y; Girón R; Maíz L; García-Clemente M; Sibila O; Golpe R; Rodríguez J; Barreiro E; Rodriguez JL; Menéndez R; Prados C; de la Rosa D; Olveira C; Arch Bronconeumol (Engl Ed); 2021 Jan; 57(1):28-35. PubMed ID: 32081438 [TBL] [Abstract][Full Text] [Related]
4. Prognostic Value of Frequent Exacerbations in Bronchiectasis: The Relationship With Disease Severity. Martinez-Garcia MÁ; Athanazio R; Gramblicka G; Corso M; Cavalcanti Lundgren F; Fernandes de Figueiredo M; Arancibia F; Rached S; Girón R; Máiz Carro L; de la Rosa Carrillo D; Prados C; Olveira C Arch Bronconeumol (Engl Ed); 2019 Feb; 55(2):81-87. PubMed ID: 30119935 [TBL] [Abstract][Full Text] [Related]
5. Impact of Chronic Bronchial Infection by García Clemente M; Olveira C; Girón R; Máiz L; Sibila O; Golpe R; Menéndez R; Rodríguez J; Barreiro E; Rodríguez Hermosa JL; Prados C; De la Rosa D; Carbajal CM; Solís M; Martínez-García MÁ J Clin Med; 2022 Jul; 11(14):. PubMed ID: 35887723 [TBL] [Abstract][Full Text] [Related]
6. High-sensitivity C-reactive protein level in stable-state bronchiectasis predicts exacerbation risk. Kwok WC; Teo KC; Lau KK; Ho JC BMC Pulm Med; 2024 Feb; 24(1):80. PubMed ID: 38350918 [TBL] [Abstract][Full Text] [Related]
7. [Hemoptysis in adults with bronchiectasis: correlation with disease severity and exacerbation risk]. Guan WJ; Yuan JJ; Gao YH; Li HM; Zhong NS; Chen RC Zhonghua Jie He He Hu Xi Za Zhi; 2017 Jan; 40(1):16-23. PubMed ID: 28100357 [No Abstract] [Full Text] [Related]
8. Pseudomonas aeruginosa and lung function decline in patients with bronchiectasis. Martinez-García MA; Oscullo G; Posadas T; Zaldivar E; Villa C; Dobarganes Y; Girón R; Olveira C; Maíz L; García-Clemente M; Sibila O; Golpe R; Rodríguez J; Barreiro E; Rodriguez JL; Feced-Olmos L; Prados C; Muriel A; de la Rosa D; Clin Microbiol Infect; 2021 Mar; 27(3):428-434. PubMed ID: 32311472 [TBL] [Abstract][Full Text] [Related]
9. Neutrophils to Lymphocyte Ratio as a Biomarker in Bronchiectasis Exacerbation: A Retrospective Study. Georgakopoulou VE; Trakas N; Damaskos C; Garmpis N; Karakou E; Chatzikyriakou R; Lambrou P; Tsiafaki X Cureus; 2020 Aug; 12(8):e9728. PubMed ID: 32944447 [TBL] [Abstract][Full Text] [Related]
10. Predicting high risk of exacerbations in bronchiectasis: the E-FACED score. Martinez-Garcia MA; Athanazio RA; Girón R; Máiz-Carro L; de la Rosa D; Olveira C; de Gracia J; Vendrell M; Prados-Sánchez C; Gramblicka G; Corso Pereira M; Lundgren FL; Fernandes De Figueiredo M; Arancibia F; Rached SZ Int J Chron Obstruct Pulmon Dis; 2017; 12():275-284. PubMed ID: 28182132 [TBL] [Abstract][Full Text] [Related]
11. Respiratory viruses in exacerbations of non-cystic fibrosis bronchiectasis in children. Kapur N; Mackay IM; Sloots TP; Masters IB; Chang AB Arch Dis Child; 2014 Aug; 99(8):749-53. PubMed ID: 24819370 [TBL] [Abstract][Full Text] [Related]
12. Utility of Bronchiectasis severity index (BSI) as prognostic tool in patients with post tubercular bronchiectasis: An experience from a tertiary care hospital in North India. Deshmukh A; Vadala R; Talwar D Indian J Tuberc; 2021 Apr; 68(2):261-265. PubMed ID: 33845962 [TBL] [Abstract][Full Text] [Related]
13. Systemic Inflammation during and after Bronchiectasis Exacerbations: Impact of Menéndez R; Méndez R; Amara-Elori I; Reyes S; Montull B; Feced L; Alonso R; Amaro R; Alcaraz V; Fernandez-Barat L; Torres A J Clin Med; 2020 Aug; 9(8):. PubMed ID: 32823681 [TBL] [Abstract][Full Text] [Related]
14. Serum hepatocyte growth factor as a predictor of disease severity and future exacerbations in patients with non-cystic fibrosis bronchiectasis. Jeong JH; Heo M; Kim EJ; Hah YS; Heo IR; Kim TH; Kim HC; Ju S; Yoo JW; Jeong YY; Lee JD; Lee SJ Respir Med; 2021; 185():106505. PubMed ID: 34139579 [TBL] [Abstract][Full Text] [Related]
15. Prognostic utility of various multidimensional grading scales among Saudi patients with bronchiectasis. Al-Harbi A; Al-Ghamdi M; Abdulrahman A; Khan M; Al-Rajhi S; Al-Jahdali H Respir Med Res; 2021 Nov; 80():100843. PubMed ID: 34174526 [TBL] [Abstract][Full Text] [Related]
16. Objective sputum colour assessment and clinical outcomes in bronchiectasis: data from the European Bronchiectasis Registry (EMBARC). Aliberti S; Ringshausen FC; Dhar R; Haworth CS; Loebinger MR; Dimakou K; Crichton ML; De Soyza A; Vendrell M; Burgel PR; McDonnell M; Skrgat S; Maiz Carro L; de Roux A; Sibila O; Bossios A; van der Eerden M; Kauppi P; Wilson R; Milenkovic B; Menendez R; Murris M; Borekci S; Munteanu O; Obradovic D; Nowinski A; Amorim A; Torres A; Lorent N; Van Braeckel E; Altenburg J; Shoemark A; Shteinberg M; Boersma W; Goeminne PC; Elborn JS; Hill AT; Welte T; Blasi F; Polverino E; Chalmers JD; Eur Respir J; 2024 Apr; 63(4):. PubMed ID: 38609095 [TBL] [Abstract][Full Text] [Related]
17. Relationship between the presence of bronchiectasis and acute exacerbation in Thai COPD patients. Kawamatawong T; Onnipa J; Suwatanapongched T Int J Chron Obstruct Pulmon Dis; 2018; 13():761-769. PubMed ID: 29535516 [TBL] [Abstract][Full Text] [Related]
18. Characterization of the "Frequent Exacerbator Phenotype" in Bronchiectasis. Chalmers JD; Aliberti S; Filonenko A; Shteinberg M; Goeminne PC; Hill AT; Fardon TC; Obradovic D; Gerlinger C; Sotgiu G; Operschall E; Rutherford RM; Dimakou K; Polverino E; De Soyza A; McDonnell MJ Am J Respir Crit Care Med; 2018 Jun; 197(11):1410-1420. PubMed ID: 29357265 [TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes of bronchiectasis in India: data from the EMBARC/Respiratory Research Network of India registry. Dhar R; Singh S; Talwar D; Murali Mohan BV; Tripathi SK; Swarnakar R; Trivedi S; Rajagopala S; D'Souza G; Padmanabhan A; Archana B; Mahesh PA; Ghewade B; Nair G; Jindal A; Jayadevappa GDH; Sawhney H; Sarmah KR; Saha K; Anantharaj S; Khanna A; Gami S; Shah A; Shah A; Dutt N; Garg H; Vyas S; Venugopal K; Prasad R; Aleemuddin NM; Karmakar S; Singh V; Jindal SK; Sharma S; Prajapat D; Chandrashekar S; Loebinger M; Mishra A; Blasi F; Ramanathan RP; Goeminne PC; Vasudev P; Shoemark A; Jayaraj BS; Kungwani R; Das A; Sawhney M; Polverino E; Welte T; Gulecha NS; Shteinberg M; Mangala A; Shah P; Chauhan NK; Jajodia N; Singhal A; Batra S; Hasan A; Aliberti S; Crichton ML; Limaye S; Salvi S; Chalmers JD; Eur Respir J; 2023 Jan; 61(1):. PubMed ID: 36229049 [TBL] [Abstract][Full Text] [Related]
20. Development and initial validation of the bronchiectasis exacerbation and symptom tool (BEST). Artaraz A; Crichton ML; Finch S; Abo-Leyah H; Goeminne P; Aliberti S; Fardon T; Chalmers JD Respir Res; 2020 Jan; 21(1):18. PubMed ID: 31931782 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]